Items where authors include "Bartenstein, P."

Article

Dilcher, R. orcid.org/0000-0002-1307-6747, Wall, S., Groß, M. et al. (27 more authors) (2024) Combining cerebrospinal fluid and PI‐2620 tau‐PET for biomarker‐based stratification of Alzheimer's disease and 4R‐tauopathies. Alzheimer's & Dementia, 20 (10). pp. 6896-6909. ISSN 1552-5260

Zatcepin, A. orcid.org/0000-0002-0224-088X, Gnörich, J., Rauchmann, B.-S. et al. (41 more authors) (2024) Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease. Molecular Neurodegeneration, 19. 64.

Stockbauer, A., Beyer, L., Huber, M. et al. (39 more authors) (2024) Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. European Journal of Nuclear Medicine and Molecular Imaging, 51. pp. 1023-1034. ISSN 1619-7070

Biechele, G., Rauchmann, B.-S., Janowitz, D. et al. (30 more authors) (2024) Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease. Journal of Neuroinflammation, 21 (1). 30. ISSN 1742-2094

Finze, A., Biechele, G., Rauchmann, B.-S. et al. (41 more authors) (2023) Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Molecular Psychiatry, 28 (10). pp. 4438-4450. ISSN 1359-4184

Völter, F., Beyer, L., Eckenweber, F. et al. (17 more authors) (2023) Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings. European Journal of Nuclear Medicine and Molecular Imaging, 50 (5). pp. 1384-1394. ISSN 1619-7070

Schuster, S., Beyer, L. orcid.org/0000-0002-7358-4495, Palleis, C. et al. (21 more authors) (2022) Impact of partial volume correction on [18F]GE-180 PET quantification in subcortical brain regions of patients with corticobasal syndrome. Brain Sciences, 12 (2). 204. ISSN 2076-3425

Lasch, F., Karch, A., Koch, A. et al. (30 more authors) (2020) Comparison of MRI and VQ-SPECT as a screening test for patients with suspected CTEPH: CHANGE-MRI study design and rationale. Frontiers in Cardiovascular Medicine, 7. 51.